BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 15352163)

  • 1. Autoinhibited proteins as promising drug targets.
    Peterson JR; Golemis EA
    J Cell Biochem; 2004 Sep; 93(1):68-73. PubMed ID: 15352163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical inhibition of N-WASP by stabilization of a native autoinhibited conformation.
    Peterson JR; Bickford LC; Morgan D; Kim AS; Ouerfelli O; Kirschner MW; Rosen MK
    Nat Struct Mol Biol; 2004 Aug; 11(8):747-55. PubMed ID: 15235593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein-protein interactions as targets for small-molecule therapeutics in cancer.
    White AW; Westwell AD; Brahemi G
    Expert Rev Mol Med; 2008 Mar; 10():e8. PubMed ID: 18353193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein-protein interactions as targets for small molecule drug discovery.
    Fry DC
    Biopolymers; 2006; 84(6):535-52. PubMed ID: 17009316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A two-state allosteric model for autoinhibition rationalizes WASP signal integration and targeting.
    Buck M; Xu W; Rosen MK
    J Mol Biol; 2004 Apr; 338(2):271-85. PubMed ID: 15066431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying novel modulators of G protein-coupled receptors via interaction at allosteric sites.
    Presland J
    Curr Opin Drug Discov Devel; 2005 Sep; 8(5):567-76. PubMed ID: 16159018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A geometry-based generic predictor for catalytic and allosteric sites.
    Mitternacht S; Berezovsky IN
    Protein Eng Des Sel; 2011 Apr; 24(4):405-9. PubMed ID: 21159618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling small molecule-compound binding to G-protein-coupled receptors.
    Vaidehi N; Pease JE; Horuk R
    Methods Enzymol; 2009; 460():263-88. PubMed ID: 19446730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. G-protein-coupled receptor allosterism: the promise and the problem(s).
    Christopoulos A; May LT; Avlani VA; Sexton PM
    Biochem Soc Trans; 2004 Nov; 32(Pt 5):873-7. PubMed ID: 15494038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rational drug design via intrinsically disordered protein.
    Cheng Y; LeGall T; Oldfield CJ; Mueller JP; Van YY; Romero P; Cortese MS; Uversky VN; Dunker AK
    Trends Biotechnol; 2006 Oct; 24(10):435-42. PubMed ID: 16876893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. G-protein-coupled receptors: from classical modes of modulation to allosteric mechanisms.
    Bridges TM; Lindsley CW
    ACS Chem Biol; 2008 Sep; 3(9):530-41. PubMed ID: 18652471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allosteric properties of G protein-coupled receptor oligomers.
    Springael JY; Urizar E; Costagliola S; Vassart G; Parmentier M
    Pharmacol Ther; 2007 Sep; 115(3):410-8. PubMed ID: 17655934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemical inhibition through conformational stabilization of Rho GTPase effectors.
    Deacon SW; Peterson JR
    Handb Exp Pharmacol; 2008; (186):431-60. PubMed ID: 18491063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small-molecule protein-protein interaction inhibitors: therapeutic potential in light of molecular size, chemical space, and ligand binding efficiency considerations.
    Buchwald P
    IUBMB Life; 2010 Oct; 62(10):724-31. PubMed ID: 20979208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoinhibitory domains: modular effectors of cellular regulation.
    Pufall MA; Graves BJ
    Annu Rev Cell Dev Biol; 2002; 18():421-62. PubMed ID: 12142282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of multiple well defined conformations on small-angle scattering of proteins in solution.
    Heller WT
    Acta Crystallogr D Biol Crystallogr; 2005 Jan; 61(Pt 1):33-44. PubMed ID: 15608373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is allostery an intrinsic property of all dynamic proteins?
    Gunasekaran K; Ma B; Nussinov R
    Proteins; 2004 Nov; 57(3):433-43. PubMed ID: 15382234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allosteric agonists of 7TM receptors: expanding the pharmacological toolbox.
    Langmead CJ; Christopoulos A
    Trends Pharmacol Sci; 2006 Sep; 27(9):475-81. PubMed ID: 16889837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-hairpin peptidomimetics: design, structures and biological activities.
    Robinson JA
    Acc Chem Res; 2008 Oct; 41(10):1278-88. PubMed ID: 18412373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.